Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Abaloparatide on Lumbar Disc Degeneration

Trial Profile

Effect of Abaloparatide on Lumbar Disc Degeneration

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Feb 2019

At a glance

  • Drugs Abaloparatide (Primary)
  • Indications Back pain
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 18 Feb 2019 Last checked against ClinicalTrials.gov: US National Institutes of Health
    • 11 Feb 2019 Planned End Date changed from 31 Dec 2022 to 31 Mar 2023.
    • 11 Feb 2019 Planned primary completion date changed from 31 Jul 2021 to 30 Nov 2021.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top